FDA
-
-
-
-
-
-
-
Bausch Health Co. Inc. (BHC) Receives Tentative FDA Approval for BRYHALI
-
-
-
-
-
-
-
Valeant Pharma (VRX) calls active as shares sell off 7.8%
-
-
-
-
-
-
-
Salix Presents Rifaximin Phase 3 Study Results for Irritable Bowel Syndrome with Diarrhea at Digestive Disease Week
-
-
-
-
-
-
-
Valeant Pharma's (VRX) Bausch + Lomb Announces FDA Approval for ULTRA Extended Wear Indication
-
-
-
-
-
-
-
Valeant Announces Fourth-Quarter And Full-Year 2017 Results And Provides 2018 Guidance
-
-
-
-
-
-
-
Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-121 Acne Treatment In Lotion Form
-
-
-
-
-
-
-
EyeGate Completes Enrollment in Phase 2b Clinical Trial of EGP-437 for Cataract Surgery
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

